[{"Assets_0_Q2_USD":750591000.0,"CommonStockSharesOutstanding_0_Q2_shares":52710633.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":40472000.0,"NetIncomeLoss_1_Q2_USD":16276000.0,"NetIncomeLoss_2_Q2_USD":30928000.0,"StockholdersEquity_0_Q2_USD":690917000.0,"EarningsPerShareBasic_1_Q2_USD":0.31,"EarningsPerShareBasic_2_Q2_USD":0.59,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":52557000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":52355000.0,"Ticker":"NEOG","CIK":"711377","name":"NEOGEN CORP","OfficialName":"Neogen Corporation Common Stock","form":"10-Q","period":"20191130","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3158444013.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20191227"}]